Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2025Hematology ReportsOpen Access

Mucosal-Associated Lymphoid Tissue Lymphoma in Southeast Asia: A 15-Year Retrospective Multicenter Study

View Full Paper
Ask AI
Bookmark
Share

Authors

KPKannadit PrayongratanaTTTanapun ThamgrangCLChonlada Laoruangroj

Discussion

Loading...

Member takes

Overview

Retrospective analysis reveals major prognostic factors affecting progression-free survival and survival rates in MALT lymphoma.

Key Points

  • Mucosal-associated lymphoid tissue lymphoma significantly influences survival, particularly in low-risk patients.
  • Low-risk patients attained 83.3% progression-free survival and 97.8% overall survival versus 66.1% and 76.7% in high-risk patients.
  • This observational analysis utilized the Thai Lymphoma Study Group registry data on lymphoma cases over 15 years.
  • Findings highlight the importance of risk classification in treatment and management of MALT lymphoma.

Cite This Study

Prayongratana et al. (2025) studied this question.

synapsesocial.com/papers/6928f106a65b730b9ea79b2bhttps://doi.org/10.3390/hematolrep17060063
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical characteristics and outcomes of extranodal marginal zone lymphoma of pulmonary mucosa-associated lymphoid tissue: A single-center retrospective study2025
  2. 2Routine interventions failed to provide survival benefits for early-stage major salivary gland marginal zone lymphoma in a population-based analysis2025
  3. 3Multi-dimensional transcriptomic profiling reveals novel tumor microenvironment landscape and subtype-specific therapeutic Vulnerabilities of MALT lymphomas2025
  4. 4Identifying high-risk patients with MALT lymphoma undergoing first-line therapy for disease progression.2025
  5. 5A Systematic Review of the Outcomes of Mucosa‐Associated Lymphoid Tissue Intracranial Lymphomas2025